Dose-Dependent actions and temporal effects of angiotensin ii on microvascular permeability

Journal of Trauma

Volumn 55, Issue 3, 2003, Pages 527-530

  Victorino, Gregory P ^a   Newton, Christopher R ^a   Curran, Brian ^a  

^a ALAMEDA COUNTY MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; Hydraulic permeability; Landis micro occlusion technique; Microvascular permeability

Indexed keywords

ANGIOTENSIN; RINGER SOLUTION;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; ERYTHROCYTE; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; SHOCK; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; CAPILLARY PERMEABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; RATS; TIME FACTORS; VASOCONSTRICTOR AGENTS;

EID: 0141857483     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000028971.15527.5B     Document Type: Article

References (26)

1. Hilton JG, Marullo DS. Trauma induced increases in plasma vasopressin and angiotensin II. Life Sci. 1987; 41: 2195-2200.
2. Michel CC, Curry FE. Microvascular permeability. Physiol Rev. 1999; 79: 703-756.
3. Robertson AL, Khairallah PA. Effect of angiotensin II and some analogs on vascular permeability in the rabbit. Circ Res. 1972; 31: 923-931.
4. Reddy HK, Campbell SE, Janicki JS, Zhou G, Weber KT. Coronary microvascular fluid flux and permeability: influence of angiotensin II, aldosterone, and acute arterial hypertension. J Lab Clin Med. 1993; 121: 510-521.
5. Williams B, Baker AQ, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscles. Hypertension. 1995; 25: 913-917.
6. Fantone JC, Schrier D, Weingarten B. Inhibition of vascular permeability changes in rats by captopril. J Clin Invest. 1982; 69: 1207-1211.
7. Hernanadez I, Carbonell LF, Quesada T, Fenoy FJ. Role of angiotensin II in modulating the hemodynamic effects of nitric oxide synthetase inhibition. Am J Physiol. 1999; 177 (1 pt 2): R104-R111.
8. Victorino GP, Newton CR, Curran B. The effect of angiotensin II on microvascular permeability. J Surg Res. 2002; 104: 77-81.
9. Victorino GP, Wisner DH, Tucker VL. Basal release of nitric oxide and its interaction with endothelin-1 on single vessel hydraulic permeability. J Trauma. 2001; 50: 535-539.
10. Victorino GP, Wisner DH, Tucker VL. Direct actions of endothelin-1 on single vessel hydraulic permeability. J Trauma. 1999; 47: 713-718.
11. He P, Wang J, Zeng M. Leukocyte adhesion and microvessel permeability. Am J Physiol. 2000; 278: H1686-H1694.
12. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol. 1998; 274 (6 pt 2): H1885-H1894.
13. Curry FE, Huxley VH, Sarelius IH. Techniques in microcirculation: measurement of permeability, pressure and flow. In: Linden RT, ed. Cardiovascular Physiology: Techniques in the Life Sciences. New York: Elsevier; 1983: 1-34.
14. Nora EH, Munzenmaier DH, Hansen-Smith FM, Lombard JH, Greene AS. Localization of the ANG II type 2 receptor in the microcirculation of skeletal muscle. Am J Physiol. 1998; 275: H1394-H1403.
15. Patel JM, Yarid FR, Block ER, Raizada MK. Angiotensin receptors in pulmonary arterial and aortic endothelial cells. Am J Physiol. 1989; 256: C987-C993.
16. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci. 1991; 12: 55-62.
17. Chorvatova A, Gallo-Payet N, Casanova C, Payet MD. Modulation of membrane potential and ionic currents by the AT1 and AT2 receptors of angiotensin II. Cell Signal. 1996; 8: 525-532.
18. Harris RC. Potential mechanisms and physiologic actions of intracellular angiotensin II. Am J Med Sci. 1999; 318: 374-379.
19. Caputo L, Benessiano J, Boulanger CM, Levy BI. Angiotensin II increases cGMP content via endothelial angiotensin II AT1 subtype receptors in the rat carotid artery. Arterioscler Thromb Vasc Biol. 1995; 15: 1646-1651.
20. Reilly PM, Bulkley GB. Vasoactive mediators and splanchnic perfusion. Crit Care Med. 1993; 21: s55-s68.
21. Adamson RH, Liu B, Fry GN, Rubin LL, Curry FE. Microvascular permeability and number of tight junctions are modulated by cAMP. Am J Physiol. 1998; 274 (6 pt 2): H1885-H1894.
22. He P, Liu B, Curry FE. Effect of nitric oxide synthetase inhibitors on endothelial [Ca2+]i and microvessel permeability. Am J Physiol. 1997; 272: H176-H185.
23. He P, Zeng M, Curry FE. cGMP modulates basal and activated microvessel permeability independently of [Ca2+]i. Am J Physiol. 1998; 274 (6 pt 2): H1865-H1874.
24. He P, Zeng M, Curry FE. Dominant role of cAMP in regulation of microvessel permeability. Am J Physiol. 2000; 278: H1124-H1133.
25. He P, Zhang X, Curry FE. Ca2+ entry through conductive pathways modulates receptor-mediated increase in microvessel permeability. Am J Physiol. 1998; 271: H2377-H2387.
26. Tadros T, Traber DL, Heggers JP, Herndon DN. Angiotensin II inhibitor DuP753 attenuates burn and endotoxin induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation. Ann Surg. 2000; 231: 566-567.